Esophagogastric Cancer

12 clinical trials · Condition

Record	Firm	Date
PET-MRI Esophagus Feasibility Study (NCT05796102)	University Health Network, Toronto	2023-03-28
A Study of Tooth Erosion in People With Esophagogastric Cancer (NCT05612048)	Memorial Sloan Kettering Cancer Center	2022-11-03
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers (NCT05544929)	Novartis Pharmaceuticals	2022-10-26
A Study of Amivantamab in People With Esophagogastric Cancer (NCT05117931)	Memorial Sloan Kettering Cancer Center	2021-12-02
Folfox+Irinotecan+Chemort In Esophageal Cancer (NCT04656041)	Massachusetts General Hospital	2021-06-29
A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer (NCT04757363)	Memorial Sloan Kettering Cancer Center	2021-02-11
A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer (NCT04161781)	Memorial Sloan Kettering Cancer Center	2019-11-12
A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing (NCT03133650)	Memorial Sloan Kettering Cancer Center	2017-04-26
Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers (NCT02296671)	Washington University School of Medicine	2015-02-01
PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer (NCT02023996)	Memorial Sloan Kettering Cancer Center	2013-12-01
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors (NCT01803282)	Gilead Sciences	2013-03-29
STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer (NCT01167114)	Massachusetts General Hospital	2010-08-01

Track Esophagogastric Cancer automatically

Every clearance here is in the API, with alerts when new ones post.